Reversible encephalopathy after cardiac transplantation: Histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression

American Journal of Neuroradiology

Volumn 30, Issue 3, 2009, Pages 588-590

  Horbinski, C ^a   Bartynski, W S ^b   Carson Walter, E ^d   Hamilton, R L ^a   Tan, H P ^a   Cheng, S ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; ASTROCYTE; BRAIN BIOPSY; CASE REPORT; CELL ACTIVATION; CELL MIGRATION; ENDOTHELIUM CELL; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PROTEIN EXPRESSION; T LYMPHOCYTE;

ASTROCYTES; BIOPSY; BRAIN EDEMA; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEURONS; POSTOPERATIVE COMPLICATIONS; RECOVERY OF FUNCTION; RNA, MESSENGER; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64649083042     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1311     Document Type: Article

References (13)

1. Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR AmJNeuroradiol 2001;22:1901-14
2. Kilinc M, Benli S, Can U, et al. FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. Transplant Proc 2002;34:1182-84
3. Lanzino G, Cloft H, Hemstreet MK, et al. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg 1997;99:222-26
4. Lavigne CM, Shrier DA, Ketkar M, et al. Tacrolimus leukoencephalopathy: a neuropathologic confirmation. Neurology 2004;63:1132-33
5. Schiff D, Lopes MB. Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2005;2:303-05
6. Thyagarajan GK, Cobanoglu A, Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997;64:1461-64
7. Misawa A, Takeuchi Y, Hibi S, et al. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:331-34
8. Schuuring J, Wesseling P, Verrips A. Severe tacrolimus leukoencephalopathy after liver transplantation. AJNR Am J Neuroradiol 2003;24:2085-88
9. Small SL, Fukui MB, Bramblett GT, et al. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996;40:575-80
10. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29: 1036-42
11. Ahn KJ, You WJ, Jeong SL, etal. Atypical manifestationsofreversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004;46:978-83
12. Takanashi J, Barkovich AJ, Shiihara T, et al. Widening spectrumofareversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 2006;27:836-38
13. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043-49